Patients pretreated with medical treatment had a higher prevalence of type 2 diabetes and lower prevalence of hypertension, higher GH levels at diagnosis, and more frequently harbored hypointense tumors than patients who did not receive medical therapy preoperatively. The gene discussed is GH1; the disease is type 2 diabetes mellitus.